Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab

BACKGROUND: Anti-angiogenic therapy with bevacizumab is the most widely used treatment option for recurrent glioblastoma, but therapeutic response varies substantially and effective biomarkers for patient selection are not available. To this end, we determine whether novel quantitative radiomic stra...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Grossmann, Patrick, Narayan, Vivek, Chang, Ken, Rahman, Rifaquat, Abrey, Lauren, Reardon, David A, Schwartz, Lawrence H, Wen, Patrick Y, Alexander, Brian M, Huang, Raymond, Aerts, Hugo J W L
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2017
Témata:
Neuroimaging
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5716072/
https://ncbi.nlm.nih.gov/pubmed/28499022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox092
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky